Title
Authorized Outlets for Nalbuphine Hydrochloride Sales
Law
Bfad Memorandum Circular No. 20 S. 1992
Decision Date
Sep 11, 1992
The Certificate of Product Registration for Nalbuphine Hydrochloride (Nubain Injection) 10 mg/mL has been amended to specify authorized outlets for sale, limiting distribution to listed pharmacies and government hospitals.
A

Authorized Outlets and Geographic Coverage

  • Only outlets officially listed are permitted to carry and dispense the product.
  • Authorized outlets include a detailed list of drugstores across Metro Manila, Luzon, Visayas, and Mindanao.
  • The list includes well-known pharmacy chains and independent drugstores in strategic locations.

Procedure for Dispensing

  • Outlets must comply strictly with the listing to legally dispense Nalbuphine Hydrochloride.
  • The amendment enforces accountability by Boots Pharmaceuticals, Inc. for supply control.

Regulatory Authority and Enforcement

  • The directive is issued by the Director of the Bureau of Food and Drugs (BFAD), granting regulatory authority.
  • BFAD will oversee and ensure compliance with the amended CPR conditions.

Legal and Public Health Implications

  • Restricting sales to authorized outlets helps prevent misuse and illegal distribution of narcotic or psychotropic substances.
  • Maintains public safety and ensures proper medical dispensing protocols are followed.

Penalties (Implied)

  • Selling Nalbuphine outside the authorized outlets may result in legal consequences under existing pharmaceutical laws and BFAD regulations.
  • Suspensions or revocation of CPR for non-compliant outlets or manufacturers may apply.

Analyze Cases Smarter, Faster
Jur helps you analyze cases smarter to comprehend faster, building context before diving into full texts. AI-powered analysis, always verify critical details.